HIGHLIGHTS
- who: Clara Udaondo from the 61, Madrid, Spain have published the article: Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases, in the Journal: (JOURNAL) of May/28,/2021
- what: In this preliminary study, we conclude that standard of care treatment for adolescents with RD, including anti TNF and MTX, does not affect the humoral and the cellular immunity to BNT162b2 mRNA_vaccination.
- future: Future studies with larger sample sizes are needed to corroborate the results . Studies are needed to evaluate the immune_response and the immunogenicity . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.